Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Nuclea Biotechnologies patents

List of Nuclea Biotechnologies patents

List of Catalogic Software patents

List of Kuraray patents

List of Square Panda patents

List of SBIR/STTR awards granted to Planet Biotechnology Incorporated

List of funding rounds for ZenCity

Patents where

Current Assignee

Name

is

Nuclea Biotechnologies

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 8685891 Method and assay for determining FAS expression	Patent 8685891 was granted and assigned to Nuclea Biotechnologies on April, 2014 by the United States Patent and Trademark Office.		Nuclea Biotechnologies		United States Patent and Trademark Office	8685891	April 1, 2014
	‌ US Patent 8278034 Methods of making frozen tissue microarrays	Patent 8278034 was granted and assigned to Nuclea Biotechnologies on October, 2012 by the United States Patent and Trademark Office.		Nuclea Biotechnologies		United States Patent and Trademark Office	8278034	October 2, 2012
	‌ US Patent D714959 Beam dump assembly	Patent D714959 was granted and assigned to Nuclea Biotechnologies on October, 2014 by the United States Patent and Trademark Office.	Nuclea Biotechnologies	Nuclea Biotechnologies		United States Patent and Trademark Office	D714959	October 7, 2014
	‌ US Patent 9056919 USP2a peptides and antibodies	Patent 9056919 was granted and assigned to Nuclea Biotechnologies on June, 2015 by the United States Patent and Trademark Office.	Nuclea Biotechnologies	Nuclea Biotechnologies		United States Patent and Trademark Office	9056919	June 16, 2015
	‌ US Patent 8729239 Antibodies against fatty acid synthase	Patent 8729239 was granted and assigned to Nuclea Biotechnologies on May, 2014 by the United States Patent and Trademark Office.		Nuclea Biotechnologies		United States Patent and Trademark Office	8729239	May 20, 2014
	‌ US Patent D718800 Lens mount	Patent D718800 was granted and assigned to Nuclea Biotechnologies on December, 2014 by the United States Patent and Trademark Office.	Nuclea Biotechnologies	Nuclea Biotechnologies		United States Patent and Trademark Office	D718800	December 2, 2014
	‌ US Patent 8900820 Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors	Patent 8900820 was granted and assigned to Nuclea Biotechnologies on December, 2014 by the United States Patent and Trademark Office.		Nuclea Biotechnologies		United States Patent and Trademark Office	8900820	December 2, 2014
	‌ US Patent 9029512 Anti-phospho-Akt antibodies	Patent 9029512 was granted and assigned to Nuclea Biotechnologies on May, 2015 by the United States Patent and Trademark Office.		Nuclea Biotechnologies		United States Patent and Trademark Office	9029512	May 12, 2015
	‌ US Patent 7897354 Kinase peptides and antibodies	Patent 7897354 was granted and assigned to Nuclea Biotechnologies on March, 2011 by the United States Patent and Trademark Office.		Nuclea Biotechnologies		United States Patent and Trademark Office	7897354	March 1, 2011
	‌ US Patent 8129125 Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors	Patent 8129125 was granted and assigned to Nuclea Biotechnologies on March, 2012 by the United States Patent and Trademark Office.		Nuclea Biotechnologies		United States Patent and Trademark Office	8129125	March 6, 2012

10 results

0 selected

10 results

0 selected